Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07598149 · ClinicalTrials.gov registry record
Glucose Levels and Outcomes in Women - Mid Pregnancy
A clinical trial, sponsored by Sanford Health.
- Not yet
- Registry status
- 50
- Enrollment target
NCT07598149: Clinical Trial study, sponsored by Sanford Health.
NCT07598149 is a clinical trial that has not yet begun recruiting, run by Sanford Health. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07598149 has not yet begun recruiting, sponsored by Sanford Health.
- NOT YET RECRUITING
- Registry status
- 50 participants
- Enrollment target
Study Summary
Up to 75% of reproductive age women are overweight, 40% are considered obese, and the prevalence of gestational diabetes mellitus (GDM) continues to rise, from 6% to 8.3% between 2016 and 2021. Currently understood GDM risk factors, such as advanced maternal age, prior history of GDM, family history of diabetes, and socioeconomic status can only explain up to 50% of cases. Related factors such as body image dissatisfaction, eating behaviors, and daily stress exposure have been linked to blood sugar metabolization, pregnancy outcomes, and the normative physiological changes that occur during pregnancy. These interrelated mechanisms may serve as additional risk factors that could help identify other women at risk of GDM. This project aims to investigate how body image dissatisfaction, eating behaviors, and daily stress exposure are associated with the metabolization of blood sugar during pregnancy. In this study the Strahm Lab will recruit 50 pregnant women to participate in a study assessing blood sugar metabolization as it is related to stress, body image dissatisfaction, and eating behaviors. The study will use continuous glucose monitoring in concert with an ecological momentary assessment protocol to assess these interrelated factors over the course of 10 days between 14 and 28 weeks gestation.
Primary Outcome
Participant will wear a Dexcom G7 CGM for 10 days to measure blood glucose levels (mg/dL)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2026-05 |
| Est. Completion | 2028-05 |
What is known before NCT07598149 opens enrollment
NCT07598149 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT07598149 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07598149 about?
NCT07598149 is a clinical study titled "Glucose Levels and Outcomes in Women - Mid Pregnancy". Up to 75% of reproductive age women are overweight, 40% are considered obese, and the prevalence of gestational diabetes mellitus (GDM) continues to rise, from 6% to 8.3% between 2016 and 2021. Currently understood GDM risk factors, such as advanced maternal age, prior history of GDM, family history...
What is the current status of trial NCT07598149?
This trial is currently not yet recruiting. The enrollment target is 50 participants. The study started on 2026-05. Estimated completion is 2028-05.
Who is sponsoring clinical trial NCT07598149?
This trial is sponsored by Sanford Health, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia